Search research articles
Contact Us
Filters
Showing results (221-230 of 236) with videos related to
Page
of 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Blood
|
December 25, 2012
Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV
Pablo Tebas, David Stein, Gwendolyn Binder-Scholl, et al.
Schizophrenia Bulletin
|
June 11, 2022
Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial
Delbert G Robinson, Nina R Schooler, Patricia Marcy, et al.
Oncotarget
|
February 23, 2018
Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor
Jonathan M Yingling, William T McMillen, Lei Yan, et al.
Immunity
|
July 31, 2012
T cell assays and MIATA: the essential minimum for maximum impact
C M Britten, S Janetzki, L H Butterfield, et al.
Blood
|
June 18, 2013
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P Linette, Edward A Stadtmauer, Marcela V Maus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 15, 2019
The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy
David A Schaer, Sandaruwan Geeganage, Nelusha Amaladas, et al.
Cancer Immunology Research
|
September 3, 2020
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
Helen Kotanides, Yiwen Li, Maria Malabunga, et al.
The American Journal of Psychiatry
|
October 21, 2015
Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program
John M Kane, Delbert G Robinson, Nina R Schooler, et al.
Journal for Immunotherapy of Cancer
|
March 17, 2016
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials
Holbrook E Kohrt, Paul C Tumeh, Don Benson, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 236) with videos related to
Sort By:
Page
of 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Blood
|
December 25, 2012
Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV
Pablo Tebas, David Stein, Gwendolyn Binder-Scholl, et al.
Schizophrenia Bulletin
|
June 11, 2022
Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial
Delbert G Robinson, Nina R Schooler, Patricia Marcy, et al.
Oncotarget
|
February 23, 2018
Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor
Jonathan M Yingling, William T McMillen, Lei Yan, et al.
Immunity
|
July 31, 2012
T cell assays and MIATA: the essential minimum for maximum impact
C M Britten, S Janetzki, L H Butterfield, et al.
Blood
|
June 18, 2013
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P Linette, Edward A Stadtmauer, Marcela V Maus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 15, 2019
The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy
David A Schaer, Sandaruwan Geeganage, Nelusha Amaladas, et al.
Cancer Immunology Research
|
September 3, 2020
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
Helen Kotanides, Yiwen Li, Maria Malabunga, et al.
The American Journal of Psychiatry
|
October 21, 2015
Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program
John M Kane, Delbert G Robinson, Nina R Schooler, et al.
Journal for Immunotherapy of Cancer
|
March 17, 2016
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials
Holbrook E Kohrt, Paul C Tumeh, Don Benson, et al.
Page
of 24